830 related articles for article (PubMed ID: 12921494)
1. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494
[TBL] [Abstract][Full Text] [Related]
2. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
[TBL] [Abstract][Full Text] [Related]
3. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L
CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326
[TBL] [Abstract][Full Text] [Related]
4. Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial.
Dowson AJ; Charlesworth BR; Green J; Färkkilä M; Diener HC; Hansen SB; Gawel M;
Headache; 2005 Jan; 45(1):17-24. PubMed ID: 15663608
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
Tuchman M; Hee A; Emeribe U; Silberstein S
CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
[TBL] [Abstract][Full Text] [Related]
6. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
Gawel M; Aschoff J; May A; Charlesworth BR;
Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
[TBL] [Abstract][Full Text] [Related]
7. Zolmitriptan nasal spray: advances in migraine treatment.
Syrett N; Abu-Shakra S; Yates R
Neurology; 2003 Oct; 61(8 Suppl 4):S27-30. PubMed ID: 14581655
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: Results of a randomized, double-blind, multi-center, parallel-group study (TEENZ).
Winner P; Farkas V; Štillová H; Woodruff B; Liss C; Lillieborg S; Raines S;
Headache; 2016 Jul; 56(7):1107-19. PubMed ID: 27329280
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and satisfaction with zolmitriptan 5 mg nasal spray for treatment of migraine in real-life practice: results of a postmarketing surveillance study.
Diener HC; Evers S
Clin Drug Investig; 2007; 27(1):59-66. PubMed ID: 17177580
[TBL] [Abstract][Full Text] [Related]
10. Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study.
Geraud G; Compagnon A; Rossi A;
Eur Neurol; 2002; 47(2):88-98. PubMed ID: 11844897
[TBL] [Abstract][Full Text] [Related]
11. Zolmitriptan: a review of its use in migraine.
Spencer CM; Gunasekara NS; Hills C
Drugs; 1999 Aug; 58(2):347-74. PubMed ID: 10473025
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of zolmitriptan nasal spray in adolescent migraine.
Lewis DW; Winner P; Hershey AD; Wasiewski WW;
Pediatrics; 2007 Aug; 120(2):390-6. PubMed ID: 17671066
[TBL] [Abstract][Full Text] [Related]
13. The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. The International 311C90 Long-term Study Group.
Headache; 1998 Mar; 38(3):173-83. PubMed ID: 9563207
[TBL] [Abstract][Full Text] [Related]
14. Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet.
Spierings EL; Rapoport AM; Dodick DW; Charlesworth B
CNS Drugs; 2004; 18(15):1133-41. PubMed ID: 15581383
[TBL] [Abstract][Full Text] [Related]
15. Zolmitriptan for acute migraine attacks in adults.
Bird S; Derry S; Moore RA
Cochrane Database Syst Rev; 2014 May; 2014(5):CD008616. PubMed ID: 24848613
[TBL] [Abstract][Full Text] [Related]
16. Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group.
Rapoport AM; Ramadan NM; Adelman JU; Mathew NT; Elkind AH; Kudrow DB; Earl NL
Neurology; 1997 Nov; 49(5):1210-8. PubMed ID: 9371896
[TBL] [Abstract][Full Text] [Related]
17. Treatment satisfaction with zolmitriptan nasal spray for migraine in a real life setting: results from phase two of the REALIZE study.
Gawel M; Aschoff J; May A; Charlesworth BR;
J Headache Pain; 2005 Oct; 6(5):405-11. PubMed ID: 16362714
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group.
Solomon GD; Cady RK; Klapper JA; Earl NL; Saper JR; Ramadan NM
Neurology; 1997 Nov; 49(5):1219-25. PubMed ID: 9371897
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study.
Loder E; Silberstein SD; Abu-Shakra S; Mueller L; Smith T
Headache; 2004 Feb; 44(2):120-30. PubMed ID: 14756849
[TBL] [Abstract][Full Text] [Related]
20. A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine.
Gallagher RM; Dennish G; Spierings EL; Chitra R
Headache; 2000 Feb; 40(2):119-28. PubMed ID: 10759911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
